Dual inhibition of PI3K and mTORC1/C2 by PKI-587 (PF-05212384) as a promising therapeutic option for pulmonary neuroendocrine tumor disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details